CTRGF yields 2.44% · PFE yields 6.20%● Live data
📍 CTRGF pulled ahead of the other in Year 1
Combined, CTRGF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CTRGF + PFE for your $10,000?
Country Garden Services Holdings Company Limited, an investment holding company, provides property management services to property owners, residents, and property developers in the People's Republic of China. It offers security, cleaning, green landscaping, gardening, repair and maintenance, and other services. The company's property management portfolio includes residential properties, commercial properties, office buildings, industrial parks, multi-purpose complexes, government buildings, hospitals, and schools, as well as other public facilities, such as airport terminals, highway service stations, scenic areas, and other non-residential properties. As of December 31, 2021, it managed 6,046 property projects. The company also provides community value-added services comprising home, home decoration, community media, value added innovation, real estate brokerage, and community area services. In addition, it offers consultancy services to property developers for the management of their pre-sale activities, as well as consultancy services for properties managed by other property management companies; and cleaning, greening, repair, and maintenance services to property developers at the pre-delivery stage. Further, the company provides sales and leasing agency services of unsold parking spaces and properties; heat supply, city, and city media services; and e-commerce services. The company was founded in 1992 and is headquartered in Foshan, the People's Republic of China.
Full CTRGF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.